Antibiotic Affects Cow Dung

Researchers assess some of the downstream effects of treating livestock with a broad-spectrum antibiotic.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

PIXABAY, LAKEWOODUCCTreating livestock with prophylactic antibiotics “may have unintended environmental impacts mediated by interactions among the wide range of micro- and macro-organisms found in agroecosystems,” researchers from the University of Colorado, Boulder, and their colleagues reported today (May 25) in Proceedings of the Royal Academy B. Specifically, the international team analyzed the downstream effects of treating cattle with a broad-spectrum antibiotic, finding that the drug—a tetracycline antibiotic—affected greenhouse gasses emitted from the animals’ dung. The team also identified residual effects on dung beetles, including alterations to the insects’ microbiomes.

“Antibiotics restructure dung beetle microbiota and modify greenhouse gas emissions from dung indicate that antibiotic treatment may have unintended, cascading ecological effects that extend beyond the target animal,” the authors wrote in their paper.

“We were surprised to find such a big increase in methane emissions in dung,” study coauthor Tobin Hammer of the University of Colorado, Boulder, told New Scientist. “We believe that the tetracycline treatment favors the growth of methanogenic archaea in the cows’ intestinal tract by reducing the bacteria in the gut.”

Hammer told BBC News it remains to be tested whether the effects apply to non-tetracycline antibiotics. Further, he said, he and his colleagues have yet to discern “whether, in terms of environmental impact of antibiotics, the problem of methane emissions ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies